Difference between revisions of "Extracellular signal-regulated kinase (ERK)"

From ISMOC
Jump to: navigation, search
m
 
(20 intermediate revisions by the same user not shown)
Line 7: Line 7:
 
<table width="100%">
 
<table width="100%">
 
  <tr>
 
  <tr>
−
   <td style="vertical-align:top">
+
   <td style="vertical-align:top;">
−
According to the topology which is found as most likely by Xu et al (2010)<ref name="Xu2010"> Tian-Rui Xu et al. (2010) "Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species." Sci Signal. 3(134):ra20. ([http://www.ncbi.nlm.nih.gov/pubmed/20234003 pmid:20234003])</ref> a kinetic model is created. Literature data is used to estimate the parameter values and their error. <br>
+
According to the topology which is found as most likely by Xu et al (2010)<ref name="Xu2010"> Tian-Rui Xu et al. (2010) "Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species." ''Sci Signal.'' 3(134):ra20. ([http://www.ncbi.nlm.nih.gov/pubmed/20234003 pmid:20234003])</ref> a kinetic model is created. Literature data is used to estimate the parameter values and their uncertainty. <br>
−
We ended up in two different models:
+
This results in a probablitiy distribution for each parameter. According to these distributions samples were drawn and for each parameter composition a steady state analysis was performed. The result of this prcedure is that each output of the model is givn with a certain uncertainty.
  
−
In one (non-modified model) only one reaction kinetic differs from  Xu et al. (2010)<ref name="Xu2010"></ref>, the [[Sos-Binding|Sos-Activation]] (purple reaction) and is assumed be a binding process rather than enzyme catalysed. Furthermore we modelled the [[ERK-Activation]] as two step reaction, with the monophosphorylated ERK as intermediate.
+
For more information about previous applications for this kind of uncertainty modelling please refer to the publications listed [[#Previous Publications about uncertainty modelling|here]].
  
−
In the other one (modified model) further kinetics were changed in addition to these modifications (marked in red). So are the [[EPAC_and_PKA-Activation_(Agonist)|activation of EPAC and PKA by an agonist]] modelled as binding, C3G-Activation is modelled in two steps, first a binding to the receptor than a phosphorylation, and the [[Ras-Activation]] process is splitted in its elementary reactions, and their kinetics are therefore mass action. <br>
+
 
 +
 
 +
Due to the literature data and the parameter measured, we changed the kinetics of some reactions and ended up in two different models:
 +
 
 +
In one (non-modified model) only one reaction kinetic differs from  Xu et al. (2010)<ref name="Xu2010"></ref>, the [[Sos-Binding|Sos-Activation]] (purple reaction) and is assumed be a binding process rather than enzyme catalysed. Furthermore we modelled the [[ERK-Activation]] as two step reaction, with the monophosphorylated ERK as intermediate.
 +
 
 +
In the other one (modified model) further kinetics were changed in addition to these modifications (marked in red). So are the [[EPAC_and_PKA-Activation_(Agonist)|activation of EPAC and PKA by an agonist]] modelled as binding, [[C3G-Activation]] is modelled in two steps, first a binding to the receptor than a phosphorylation, and the [[Ras-Activation]] process is splitted in its elementary reactions, and their kinetics are therefore mass action. <br>
 
The differentiation in two different models is made to gain one model which is as close as possible to Xu et al. (2010)<ref name="Xu2010"> Tian-Rui Xu et al. (2010) "Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species." ''Sci Signal.'' 3(134):ra20. ([http://www.ncbi.nlm.nih.gov/pubmed/20234003 pmid:20234003])</ref> and another one, in which the reaction mechanism resemble the published one and therefore more measured parameter are available.
 
The differentiation in two different models is made to gain one model which is as close as possible to Xu et al. (2010)<ref name="Xu2010"> Tian-Rui Xu et al. (2010) "Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species." ''Sci Signal.'' 3(134):ra20. ([http://www.ncbi.nlm.nih.gov/pubmed/20234003 pmid:20234003])</ref> and another one, in which the reaction mechanism resemble the published one and therefore more measured parameter are available.
  
Line 25: Line 31:
  
 
<imagemap>
 
<imagemap>
−
File:L_MAPK_SignallingNetwork.png|600px|
+
File:L_MAPK_komplett.png|frameless|600px
  
 
rect 130 435 179 467 [[C3G-Activation|C3G-Activation]]
 
rect 130 435 179 467 [[C3G-Activation|C3G-Activation]]
Line 106: Line 112:
  
 
<h2>Model File </h2>
 
<h2>Model File </h2>
 +
[[File:MAPK-PPA2.xml]]
 +
 +
<h2>Equilibrium constants</h2>
 +
[[Equilibrium constants]]
 +
 +
<h2> Parameter Overview </h2>
 +
[[Parameter Overview]]
 +
 +
<h2> Previous Publications about uncertainty modelling </h2>
 +
*Achcar, F., Kerkhoven, E., Bakker, B., Barrett, M. & Breitling, R (2012). "Dynamic modelling under uncertainty: The case of Trypanosoma brucei energy metabolism." ''PLoS Computational Biology'', 8(1):e1002352 [http://www.ncbi.nlm.nih.gov/pubmed/22379410 pmid:22379410]
 +
 +
*Breitling R, Achcar F, Takano E. (2013) "Modeling challenges in the synthetic biology of secondary metabolism." ''ACS Synth Biol.'', 2(7):373-8. doi: 10.1021/sb4000228 [http://www.ncbi.nlm.nih.gov/pubmed/23659212 pmid:23659212]
 +
 +
*Achcar F, Barrett MP, Breitling R. (2013) "Explicit consideration of topological and parameter uncertainty gives new insights into a well-established model of glycolysis." ''FEBS J.'' 280(18):4640-51 [http://www.ncbi.nlm.nih.gov/pubmed/23865459 pmid:23865459]
 +
 +
*Kerkhoven EJ, Achcar F, Alibu VP, Burchmore RJ, Gilbert IH, Trybiło M, Driessen NN, Gilbert D, Breitling R, Bakker BM, Barrett MP. (2013) "Handling uncertainty in dynamic models: the pentose phosphate pathway in Trypanosoma brucei." ''PLoS Comput Biol.'' 9(12):e1003371. [http://www.ncbi.nlm.nih.gov/pubmed/24339766 pmid:24339766]
 +
 +
*[http://2013.igem.org/Team:Manchester/Enzyme Igem Team Manchester 2013]
  
 
<h2>References</h2>
 
<h2>References</h2>
 
<references/>
 
<references/>

Latest revision as of 08:15, 3 August 2014

Description of the model

According to the topology which is found as most likely by Xu et al (2010)[1] a kinetic model is created. Literature data is used to estimate the parameter values and their uncertainty.
This results in a probablitiy distribution for each parameter. According to these distributions samples were drawn and for each parameter composition a steady state analysis was performed. The result of this prcedure is that each output of the model is givn with a certain uncertainty.

For more information about previous applications for this kind of uncertainty modelling please refer to the publications listed here.


Due to the literature data and the parameter measured, we changed the kinetics of some reactions and ended up in two different models:

In one (non-modified model) only one reaction kinetic differs from Xu et al. (2010)[1], the Sos-Activation (purple reaction) and is assumed be a binding process rather than enzyme catalysed. Furthermore we modelled the ERK-Activation as two step reaction, with the monophosphorylated ERK as intermediate.

In the other one (modified model) further kinetics were changed in addition to these modifications (marked in red). So are the activation of EPAC and PKA by an agonist modelled as binding, C3G-Activation is modelled in two steps, first a binding to the receptor than a phosphorylation, and the Ras-Activation process is splitted in its elementary reactions, and their kinetics are therefore mass action.
The differentiation in two different models is made to gain one model which is as close as possible to Xu et al. (2010)[1] and another one, in which the reaction mechanism resemble the published one and therefore more measured parameter are available.


The network topology is shown in the graph besides.
Click on a reaction to have more information about it.

C3G-ActivationEGF-BindingSos-BindingSos-RemovalSos-RemovalSos-RemovalSos-RemovalERK-InactivationERK-InactivationERK-ActivationERK-ActivationMEK-InactivationRaf1-InactivationC3G-InactivationMEK-Activation(BRaf)MEK-Activation(Raf1)BRaf-InactivationBRaf-Activation(Ras)BRaf-Activation(Rap1)Raf1-ActivationRas-ActivationRas-Inactivation(GAP)Rap1-InactivationRap1-ActivationRap1-ActivationEPAC-Activation(EPACA)PKA-Activation(PKA)EPAC-Activation(Cilostamide)PKA-Activation(Cilostamide)EPAC-InactivationPKA-InactivationRaf1-RemovalL MAPK komplett.png
About this image

Reactions

Model File

File:MAPK-PPA2.xml

Equilibrium constants

Equilibrium constants

Parameter Overview

Parameter Overview

Previous Publications about uncertainty modelling

  • Achcar, F., Kerkhoven, E., Bakker, B., Barrett, M. & Breitling, R (2012). "Dynamic modelling under uncertainty: The case of Trypanosoma brucei energy metabolism." PLoS Computational Biology, 8(1):e1002352 pmid:22379410
  • Breitling R, Achcar F, Takano E. (2013) "Modeling challenges in the synthetic biology of secondary metabolism." ACS Synth Biol., 2(7):373-8. doi: 10.1021/sb4000228 pmid:23659212
  • Achcar F, Barrett MP, Breitling R. (2013) "Explicit consideration of topological and parameter uncertainty gives new insights into a well-established model of glycolysis." FEBS J. 280(18):4640-51 pmid:23865459
  • Kerkhoven EJ, Achcar F, Alibu VP, Burchmore RJ, Gilbert IH, Trybiło M, Driessen NN, Gilbert D, Breitling R, Bakker BM, Barrett MP. (2013) "Handling uncertainty in dynamic models: the pentose phosphate pathway in Trypanosoma brucei." PLoS Comput Biol. 9(12):e1003371. pmid:24339766

References

  1. ↑ 1.0 1.1 1.2 Tian-Rui Xu et al. (2010) "Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species." Sci Signal. 3(134):ra20. (pmid:20234003)
Retrieved from ‘http://www.systemsbiology.ls.manchester.ac.uk/wiki/index.php?title=Extracellular_signal-regulated_kinase_(ERK)&oldid=1946’